All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.

The ALL Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

How can NK cells act as reliable predictors and be translated to diagnostics and treatment in ALL?

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the ALL Hub spoke to Srividya Swaminathan, The Department of Systems Biology at the Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. We asked, How can natural killer (NK) cells act as reliable predictors and be translated to diagnostics and treatment in ALL?

How can NK cells act as reliable predictors and be translated to diagnostics and treatment in ALL?

Swaminathan reports the results of a study evaluating the phenotypic and functional deficiencies in NK cells of high-risk patients with ALL. Results from this study show that activated NK signature predicts poor clinical prognosis in high-risk patients with ALL.


Share: